Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 3089-3095

  Samaila, Daniel ^a   Toy, Beau J ^b   Wang, Robert C ^c   Elegbede, J Abiodun ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b Nevada Radiation Oncology Centers   (United States)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Chemo radiation; Head and neck cancer; Monoterpenes

Indexed keywords

DRUG METABOLITE; PERILLIC ACID; PERILLYL ALCOHOL; RADIOSENSITIZING AGENT; TERPENE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CYCLE; CELL CYCLE ARREST; CELL STRAIN BROTO; CELL STRAIN HTB 43; CELL STRAIN SCC 25; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CYCLOHEXENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MONOTERPENES; RADIATION-SENSITIZING AGENTS; TUMOR STEM CELL ASSAY;

EID: 6444242718     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. American Cancer Society, Cancer Facts & Figures 2004, American Cancer Society, Inc., Atlanta, GA, 2004.
2. Yokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt, ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR and Haraf DJ: Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck. J Clin Oncol 21: 320-326, 2003.
3. Merlano M, Vitale V, Rosso R, Benasso M, Corvo R, Cavallari M, Sanguineti G, Bacigalupo A, Badellino F, Margarino G et al: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327: 1115-1121, 1992.
4. Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, Hanchett C, Los G and Howell SB: Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer J Clin Oncol 12: 2113-2120, 1994
5. El-Sayed S and Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14: 838-847, 1996.
6. Yokes EE, Kies SM, Haraf JD, Stenson K, List MA, Humerickhouse M, Dolan EM, Pelzer H, Sulzen L, Witt EM, Hsieh CY, Mittal BB and Weichselbaum RR: Concomitant chemotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 18(8): 1652-1661, 2000.
7. Ganly I and Kaye SB: Recurrent squamous-cell carcinoma of the head and neck: Overview of current therapy and future prospects. Ann Oncol 11: 11-16, 2000.
8. Kies MS, Haraf DJ, Rosen FH, Stenson K, List M, Brockstein B, Chung T, Mittal BB, Pelzer H, Portugal L, Rademaker A, Weichselbaum R and Yokes EE: Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19: 1961-1969, 2001.
9. Chayet L, Rojas C, Cardemil E, Jabalquinto AM, Vicuna R and Cori O: Biosynthesis of monoterpene hydrocarbons from (1-3H) neryl pyrophosphate and (1-3H) geranyl pyrophosphate by soluble enzymes from citrus limonum. Arch Biochem Biophys 180: 318-327, 1977.
10. Alonso WR, Rajaonarivony JIM, Gershenzon J and Croteau R: Purification of 4S-limonene synthase, a monoterpene cyclase from the glandular trichomes of peppermint (Mentha x piperta) and spearmint (Mentha spicata). J Biol Chem 267: 7582-7587, 1992.
11. Kjonaas R and Croteau R: Demonstration that limonene is the first cyclic intermediate in the biosynthesis of oxygenated p-menthane monoterpenes in Mentha piperita and other Mentha species. Arch Biochem Biophys 220: 79-89, 1983.
12. Reddy BS, Wang CX, Samaha H, Lubet R, Steele VE, Kelloff GJ and Rao CV: Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57: 420-425, 1997
13. Elegbede JA, Maltzman TH, Elson CE and Gould MN: Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes. Carcinogenesis 14: 1221-1223, 1993.
14. Austin CA, Shephard EA, Pike S F, Rabin BR and Philips IR: The effect of terpenoid compounds on cytochrome P-450 levels in rat liver. Biochem Pharmacol 37: 2223-2229, 1988.
15. Crowell PL, Ren Z, Lin S, Vedejs E and Gould MN: Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol 47: 1405-15, 1994.
16. Chow SH, Salazar D and Hakim AI: Pharmacokinetics of perillic acid in humans after a single dose administration of citrus preparation rich in d-limonene content. Cancer Epidem Biom Prev 11: 1472-1476, 2002.
17. Morgan-Meadows S, Dubey S, Gould MN, Tutsch K, Marnocha R, Arzoomanin R, Alberti D, Binger K, Feierabend C, Volkman J, Ellingen S, Black S, Pomplun M, Wilding G and Bailey H: Phase I trial of perillyl alcohol administered four times daily continuously. Cancer Chemother Pharmacol 52: 361-366, 2003.
18. Rajesh D, Stenzel AR and Howard PS: Perillyl alcohol as a radio/chemosensitizer in maglinant glioma. J Biol Chem 275: 35968-35978, 2003.
19. Rajesh D and Howard PS: Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in the prostate cancer cells. The Prostate 57: 14-23, 2003
20. Elegbede JA, Flores R and Wang RC: Perillyl alcohol and perillaldehyde induced cell cycle arrest and cell death in Broto and A549 cells cultured in vitro. Life Sciences 73: 2831-2840, 2003.